Fibroids with atypical presentation and related surgical challenges: case series

Authors

  • Rosy Khanam Department of Obstetrics and Gynecology, ESIC Model Hospital, Beltola, Guwahati, Assam, India
  • Bhaswati Hazarika Department of Obstetrics and Gynecology, ESIC Model Hospital, Beltola, Guwahati, Assam, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243956

Keywords:

Leiomyoma, Atypical presentation, Hysterectomy

Abstract

Uterine fibroids refer to benign growth arising from uterus and are considered to be the most common gynaecological tumour mostly seen in women of reproductive age group. Myomas or uterine fibroids in majority may be asymptomatic and are diagnosed incidentally on imaging or on clinical examination. Significant morbidity can be caused by uterine fibroids by causing uterine bleeding, anemia, bulk symptoms and fertility issues. Quality of life can be severely affected in women with symptomatic fibroids. Uterine fibroids can be diagnosed early by ultrasound and magnetic resonance imaging (MRI). However, certain cases may present with unusual ultrasound and MRI reports causing diagnostic dilemma. Currently it is the most common indication for hysterectomy worldwide. We report 6 cases of uterine fibroids with atypical presentation with respect to location and features that caused diagnostic challenges and difficult surgeries that were performed at our institution.

Metrics

Metrics Loading ...

References

Berek JS. Benign diseases of the female reproductive tract. In: Novel’s Gynecology. 13th Edition. Philadelphia: Lippincott Williams and Wilkins. 2002;380.

Gross KL, Panhuysen CI, Kleinman MS, Goldhammer H, Jones ES, Nassery N, et al. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer. 2004;41(3):183-90.

Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473-480.

American Association of Gynecologic Laparoscopists (AAGL): Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas. J Minim Invasive Gynecol. 2012;19(2):152-71.

Kriplani A, Awasthi D, Kulshrestha V, Agarwal N. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma. Int J Gynaecol Obstet. 2012;116:35-8.

Gutmann JN, Corson SL. GnRH agonist therapy before myomectomy or hysterectomy. J Minim Invasive Gynecol. 2005;12:529-37.

Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473-80.

Qin J, Yang T, Kong F, Zhou Q. Oral contraceptive use and uterine leiomyoma risk: A meta-analysis based on cohort and case-control studies. Arch Gynecol Obstet. 2013;288:139-48.

Kumar P, Malhotra N. Jeffcoate’s Principles of Gynaecology, New Delhi: Jaypee Brothers. 2008;492.

Duhan N, Rajotia N, Duhan U, Sangwan N, Gulati N, Sirohiwal D. Isthmic uterine fibroids: the dynamics of growth. Arch Gynecol Obstet. 2009;280(2):309-12.

Downloads

Published

2024-12-27

How to Cite

Khanam, R., & Hazarika, B. (2024). Fibroids with atypical presentation and related surgical challenges: case series. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(1), 229–233. https://doi.org/10.18203/2320-1770.ijrcog20243956

Issue

Section

Case Series